| Jeffrey W Pro, MD | |
|
1850 E Park Ave, Suite 302, State College, PA 16803-6706 | |
| (814) 278-4680 | |
| (814) 235-1523 |
| Full Name | Jeffrey W Pro |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 31 Years |
| Location | 1850 E Park Ave, State College, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114980208 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD058797L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advantage Home Health Services, Llc | Altoona, PA | Home health agency |
| Family Hospice And Palliative Care | Altoona, PA | Hospice |
| Mount Nittany Medical Center | State college, PA | Hospital |
| Geisinger Medical Center | Danville, PA | Hospital |
| Geisinger-lewistown Hospital | Lewistown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mount Nittany Medical Center Health Services Inc | 8426136797 | 196 |
| Phoenix Rehabilitation And Health Services Inc | 3476464298 | 51 |
News Archive
Gilead Sciences, Inc. today announced that detailed results from four Phase 3 clinical trials (NEUTRINO, FISSION, POSITRON and FUSION) evaluating sofosbuvir, the company's investigational once-daily nucleotide NS5B inhibitor for the treatment of chronic hepatitis C virus infection, will be presented this week in oral sessions at the 48th Annual Meeting of the European Association for the Study of the Liver in Amsterdam, The Netherlands.
Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute is the only cancer center in Los Angeles to receive a Commission on Cancer 2011 Outstanding Achievement Award for providing quality care and services to cancer patients.
Clinical Data, Inc. (NASDAQ: CLDA) today announced the Company's operational and financial results for its third fiscal quarter ended December 31, 2009, confirming its plans to submit a new drug application (NDA) for vilazodone for the treatment of depression this quarter.
New research suggests a way to treat "lazy eye" that may be easier on children - and their parents - than current treatments.
› Verified 6 days ago
| Entity Name | Mount Nittany Medical Center Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164691499 PECOS PAC ID: 8426136797 Enrollment ID: O20081021000240 |
News Archive
Gilead Sciences, Inc. today announced that detailed results from four Phase 3 clinical trials (NEUTRINO, FISSION, POSITRON and FUSION) evaluating sofosbuvir, the company's investigational once-daily nucleotide NS5B inhibitor for the treatment of chronic hepatitis C virus infection, will be presented this week in oral sessions at the 48th Annual Meeting of the European Association for the Study of the Liver in Amsterdam, The Netherlands.
Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute is the only cancer center in Los Angeles to receive a Commission on Cancer 2011 Outstanding Achievement Award for providing quality care and services to cancer patients.
Clinical Data, Inc. (NASDAQ: CLDA) today announced the Company's operational and financial results for its third fiscal quarter ended December 31, 2009, confirming its plans to submit a new drug application (NDA) for vilazodone for the treatment of depression this quarter.
New research suggests a way to treat "lazy eye" that may be easier on children - and their parents - than current treatments.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey W Pro, MD 1850 E Park Ave, Suite 302, State College, PA 16803-6706 Ph: (814) 278-4680 | Jeffrey W Pro, MD 1850 E Park Ave, Suite 302, State College, PA 16803-6706 Ph: (814) 278-4680 |
News Archive
Gilead Sciences, Inc. today announced that detailed results from four Phase 3 clinical trials (NEUTRINO, FISSION, POSITRON and FUSION) evaluating sofosbuvir, the company's investigational once-daily nucleotide NS5B inhibitor for the treatment of chronic hepatitis C virus infection, will be presented this week in oral sessions at the 48th Annual Meeting of the European Association for the Study of the Liver in Amsterdam, The Netherlands.
Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute is the only cancer center in Los Angeles to receive a Commission on Cancer 2011 Outstanding Achievement Award for providing quality care and services to cancer patients.
Clinical Data, Inc. (NASDAQ: CLDA) today announced the Company's operational and financial results for its third fiscal quarter ended December 31, 2009, confirming its plans to submit a new drug application (NDA) for vilazodone for the treatment of depression this quarter.
New research suggests a way to treat "lazy eye" that may be easier on children - and their parents - than current treatments.
› Verified 6 days ago
Paul Andrew Koberna, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2134 Sandy Dr Ste 16, State College, PA 16803 Phone: 814-272-5805 Fax: 814-272-0110 | |
Peter F. Pepe, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1850 E Park Ave, Suite 201, State College, PA 16803 Phone: 814-234-8800 | |
Keriann Nickola Gray, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Scenery Dr., State College, PA 16801 Phone: 814-231-4560 Fax: 814-231-6246 | |
Dr. Manisha N. Patel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Scenery Dr, State College, PA 16801 Phone: 814-231-4560 Fax: 814-231-6246 | |
Dr. Joel B Haight, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 32 Colonnade Way, State College, PA 16803 Phone: 814-272-4445 Fax: 814-272-4450 | |
Dr. Scott A. Sulman, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Scenery Dr, State College, PA 16801 Phone: 814-231-4560 Fax: 814-235-5512 |